# InvaGen Pharmaceuticals, Inc. – FDA Inspection, Mar 30, 2017

Source: https://www.keypedia.com/records/fda_inspections/invagen-pharmaceuticals-inc/dcaac525-f15c-4af7-b544-7f96f6648e7f
Source feed: FDA_Inspections

> FDA inspection 1007073 of InvaGen Pharmaceuticals, Inc., March 30, 2017. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 16 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1007073
- Company Name: InvaGen Pharmaceuticals, Inc.
- Inspection Date: 2017-03-30
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1302076 - 2026-02-09](https://www.keypedia.com/records/fda_inspections/invagen-pharmaceuticals-inc/6f49afaf-f928-4ba0-a5bc-1df3f32d761d)
- FDA Inspection 1223321 - 2023-10-25
- [FDA Inspection 1111971 - 2019-12-06](https://www.keypedia.com/records/fda_inspections/invagen-pharmaceuticals-inc/c8e75b2a-217b-40b5-9c72-f760213ca045)
- [FDA Inspection 1053263 - 2018-05-25](https://www.keypedia.com/records/fda_inspections/invagen-pharmaceuticals-inc/e3d4a9c8-e980-4a32-9fdf-d26c6a11a868)
- FDA Inspection 970802 - 2016-04-20

## Related Officers

- [Dipesh K. Shah](https://www.keypedia.com/people/dipesh-k-shah/d4df4040-13d1-477b-8c21-4c8e5b3fc5b9)

Company: https://www.keypedia.com/companies/invagen-pharmaceuticals-inc/8841516b-25bb-463f-9666-11b69458c306

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c